News & Events
-
January 17, 2019
Critical Path Institute Celebrates Expanded Operations with Opening of European Headquarters
C-Path in the EU will work to accelerate the development of new therapies through innovative methodologies for endorsement by regulators of pharmaceutical products TUCSON, Ariz., January 17, 2019 — Critical Path Institute (C-Path) is excited to announce the launch of Critical Path Institute, Ltd. (C-Path, Ltd.) in Ireland, a fully-owned subsidiary that will enable C-Path to... -
January 8, 2019
Flinn Foundation Awards Critical Path Institute and TGen North a New Grant to Develop and Pilot a System to Respond to Antimicrobial Resistance
TUCSON, Ariz., January 8, 2019 — Critical Path Institute (C-Path) and Flagstaff, Arizona-based TGen North — the Pathogen and Microbiome Division of the Translational Genomics Research Institute (TGen) — have received a Phase 1 Concept Validation grant from the Flinn Foundation, of $400,000 over 12 months, to develop and pilot a framework enabling the state... -
January 4, 2019
At the IBD Biomarker Summit, Hosted by the Crohn’s & Colitis Foundation, C-Path Shares the Case for formation of an IBD Biomarker Consortium
At the IBD Biomarkers Summit, hosted by the Crohn’s & Colitis Foundation on October 17-18, 2018, in Newark, N.J., Critical Path Institute (C-Path) highlighted the need for an Inflammatory Bowel Disease (IBD) focused consortium with the goal to qualify biomarkers as tools to support IBD drug development programs. The two-day participatory event featured presentations and... -
December 21, 2018
C-Path Board Member Paula Olsiewski Honored as AAAS 2018 Elected Fellow
Paula Olsiewski, Ph.D., program director at the Alfred P. Sloan Foundation and Critical Path Institute board member, was named a 2018 Fellow in the Section on Chemistry by the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers, and is presented... -
December 19, 2018
In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science Workshop
At its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzheimer’s Disease (CPAD) consortium hosted key stakeholders who gathered to review the progress made made over the past year and identify and prioritize regulatory science needs for Alzheimer disease (AD) and related dementias. At the meeting,...